Share the post "Welcure Drugs & Pharmaceuticals announced Financial Results Q1 2024-25"
Highlights
- The presented financial data is Standalone to provide a comprehensive overview of the company performance.
- Profit over the Year and quarter: Significant improvement in profitability for Welcure Drugs & Pharmaceuticals ltd. Notable increase of 945.45 % in net profit Year to Year, Welcure Drugs & Pharmaceuticals ltd’s profitability increased by 1816.67 % in this quarter.
- EPS over the Year and quarter: EPS decreased by -2700 % in previous quarter. Analysis needed for shareholder value.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
Expenses | Rs. 0.03 Cr | Rs. 0.05 Cr | Rs. 0.34 Cr | + 580 % | + 1033.33 % |
Operating Profit | Rs. -0.03 Cr | Rs. -0.05 Cr | Rs. -0.34 Cr | -580 % | -1033.33 % |
OPM % | 0 % | 0 % | 0 % | 0 % | 0 % |
Other Income | Rs. 0 Cr | Rs. 0.056 Cr | Rs. 0 Cr | 0 % | 0 % |
Interest | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
Depreciation | Rs. 0 Cr | Rs. 0.02 Cr | Rs. 0 Cr | 0 % | 0 % |
Profit before tax | Rs. -0.03 Cr | Rs. -0.01 Cr | Rs. -0.34 Cr | -3300 % | -1033.33 % |
Tax % | -0 % | -0 % | -0 % | 0 % | 0 % |
Net Profit | Rs. -0.03 Cr | Rs. -0.02 Cr | Rs. -0.35 Cr | -1650 % | -1066.67 % |
EPS in Rs | Rs. 0 | Rs. -0.01 | Rs. -0.26 | -2500 % | 0 % |
Today, we’re looking at Welcure Drugs & Pharmaceuticals ltd’s financial performance for the Q1(Jun 2024).Expenses ticked up slightly by 580 % quarter-on-quarter, aligning with the annual rise of 1033.33 %. Operating profit, while down -1033.33 % compared to last year, faced a quarter-on-quarter dip of -580 %, signaling a short-term contraction in margins.
Profit before tax declined annually by -1033.33 % but saw a reduction from the preceding quarter by -3300 %.
Net profit fell by -1066.67 % year-on-year but witnessed a -1650 % contraction from the last quarter. but a quarterly fall of -2500 %. In summary, Welcure Drugs & Pharmaceuticals ltd’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
Expenses | Rs. 0.03 Cr | Rs. 0.05 Cr | Rs. 0.34 Cr | + 580 % | + 1033.33 % |
Operating Profit | Rs. -0.03 Cr | Rs. -0.05 Cr | Rs. -0.34 Cr | -580 % | -1033.33 % |
Net Profit | Rs. -0.03 Cr | Rs. -0.02 Cr | Rs. -0.35 Cr | -1650 % | -1066.67 % |
EPS in Rs | Rs. 0 | Rs. -0.01 | Rs. -0.26 | -2500 % | 0 % |
In reviewing Welcure Drugs & Pharmaceuticals ltd’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Expenses rose by 1033.33 % compared to the previous year, with a 580 % increase quarter-on-quarter. Operating Profit dropped by -1033.33 % annually, and saw a -580 % decrease from the last quarter.
Net Profit showed yearly decrease of -1066.67 %, and experienced a -1650 % decrease from the previous quarter. however dipped by -2500 % compared to the last quarter. In essence, while Welcure Drugs & Pharmaceuticals ltd faces strong annual decline indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.